Actively Recruiting
Video-supervised Motor and Awareness Training in Writer's Cramp
Led by University Hospital Schleswig-Holstein · Updated on 2024-12-10
54
Participants Needed
1
Research Sites
340 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Writer's cramp is the most common task-specific dystonia. It is characterized by involuntary co-contraction of antagonistic muscles during writing. This disabling condition may force patients to give up their occupation. In this study the efficacy of a twelve months long-term training in patients with writer's cramp will be investigated. Two different programs will be offered: The first one will consist of a sensorimotor, the second one of an awareness training. All patients will benefit from video-based supervision with the aim to establish a practice-oriented therapeutic approach that will be available to all patients independently of their home location. The treatment effect will be measured primary with the patient-centered Canadian Occupational Performance Measure (COPM) and secondary with clinical scales to assess the clinical efficacy and everyday constraints. Writing will be assessed with a computer-based kinematic writing analysis. To evaluate the influence on the brain network, several functional magnetic resonance imaging (fMRI) evaluations will be performed. This project is of minimal risk without negative side effects from the training. The risks for the MRI experiment are equal to a non-contrast standard MRI investigation.
CONDITIONS
Official Title
Video-supervised Motor and Awareness Training in Writer's Cramp
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Right handed idiopathic writer's cramp according to standardized criteria (including simple and complex forms and any dystonic posture such as flexion, extension, pronation, supination)
- Ability to participate in video-calls
You will not qualify if you...
- Presence of additional neurological or psychiatric diseases
- Left-handed patients
- Botulinum toxin treatment within the last 3 months or remaining weakness from last injection
- Use of anticholinergics or sedating medication
- Cardiac pacemaker, electronic or metal implants (for MRI exclusion)
- Pregnancy or suspected pregnancy (for MRI exclusion)
- Severe ametropia or anxiety in small rooms (for MRI exclusion)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kiel University
Kiel, Schleswig-Holstein, Germany, 24105
Actively Recruiting
Research Team
K
Kirsten E Zeuner, Prof. MD
CONTACT
A
Arne Knutzen, M.Sc. OT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here